Balyasny Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
+969,979
| New | +$10.9M | 0.02% | 673 |
|
|
2024
Q3 | – | Sell |
-375,411
| Closed | -$3.97M | – | 2305 |
|
|
2024
Q2 | $3.97M | Buy |
+375,411
| New | +$3.97M | 0.01% | 885 |
|
|
2024
Q1 | – | Sell |
-360,551
| Closed | -$4.05M | – | 2367 |
|
|
2023
Q4 | $4.05M | Buy |
+360,551
| New | +$4.05M | 0.01% | 835 |
|
|
2022
Q4 | – | Sell |
-1,753,210
| Closed | -$5.65M | – | 2680 |
|
|
2022
Q3 | $5.65M | Buy |
1,753,210
+1,437,970
| +456% | +$4.63M | 0.02% | 714 |
|
|
2022
Q2 | $1.28M | Buy |
+315,240
| New | +$1.28M | ﹤0.01% | 1317 |
|